4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000950170-24-108533
President and CEO sold 16,307 shares at an average $24.19 ($394,441)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd President and CEO | 2024-09-18 | Sale 10b5-1 | −3,500 | $24.00 | $84,000 | 1,502,427 | D |
| Harris Todd President and CEO | 2024-09-19 | Sale 10b5-1 | −5,671 | $24.30 | $137,813 | 1,496,756 | D |
| Harris Todd President and CEO | 2024-09-19 | Sale 10b5-1 | −27 | $25.10 | $678 | 1,496,729 | D |
| Harris Todd President and CEO | 2024-09-20 | Sale 10b5-1 | −7,109 | $24.19 | $171,950 | 1,489,620 | D |
| Open-market sales · 16,307 sh · avg $24.19 · $394,441 | |||||||
Loading xslF345X05/ownership.xml…